Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

ABSTRACT:

SUBMITTER: Southern KW 

PROVIDER: S-EPMC8094390 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature